Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor
- PMID: 11834837
- DOI: 10.1126/science.1065173
Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor
Abstract
DNA methylation of tumor suppressor genes is a frequent mechanism of transcriptional silencing in cancer. The molecular mechanisms underlying the specificity of methylation are unknown. We report here that the leukemia-promoting PML-RAR fusion protein induces gene hypermethylation and silencing by recruiting DNA methyltransferases to target promoters and that hypermethylation contributes to its leukemogenic potential. Retinoic acid treatment induces promoter demethylation, gene reexpression, and reversion of the transformed phenotype. These results establish a mechanistic link between genetic and epigenetic changes during transformation and suggest that hypermethylation contributes to the early steps of carcinogenesis.
Comment in
-
Cancer research. Leukemia protein spurs gene silencing.Science. 2002 Feb 8;295(5557):943-5. doi: 10.1126/science.295.5557.943b. Science. 2002. PMID: 11834787 No abstract available.
-
Cancer epigenetics and methylation.Science. 2002 Sep 13;297(5588):1807-8; discussion 1807-8. doi: 10.1126/science.297.5588.1807d. Science. 2002. PMID: 12229925 No abstract available.
Similar articles
-
Cancer research. Leukemia protein spurs gene silencing.Science. 2002 Feb 8;295(5557):943-5. doi: 10.1126/science.295.5557.943b. Science. 2002. PMID: 11834787 No abstract available.
-
PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter.Ann Hematol. 2006 Oct;85(10):689-704. doi: 10.1007/s00277-006-0148-7. Epub 2006 Jul 11. Ann Hematol. 2006. PMID: 16832676
-
Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo.Oncogene. 2005 Mar 10;24(11):1820-30. doi: 10.1038/sj.onc.1208286. Oncogene. 2005. PMID: 15688037
-
Epigenetic gene silencing in acute promyelocytic leukemia.Biochem Pharmacol. 2004 Sep 15;68(6):1247-54. doi: 10.1016/j.bcp.2004.05.041. Biochem Pharmacol. 2004. PMID: 15313423 Review.
-
[Acute promyelocytic leukemia, histone deacetylase, and response to retinoids].Bull Cancer. 1998 Apr;85(4):301-3. Bull Cancer. 1998. PMID: 9752292 Review. French.
Cited by
-
A major epigenetic programming mechanism guided by piRNAs.Dev Cell. 2013 Mar 11;24(5):502-16. doi: 10.1016/j.devcel.2013.01.023. Epub 2013 Feb 21. Dev Cell. 2013. PMID: 23434410 Free PMC article.
-
Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.Blood. 2009 Dec 24;114(27):5415-25. doi: 10.1182/blood-2008-10-182071. Epub 2009 Oct 1. Blood. 2009. PMID: 19797526 Free PMC article.
-
The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients.Int J Mol Sci. 2023 Jul 27;24(15):12037. doi: 10.3390/ijms241512037. Int J Mol Sci. 2023. PMID: 37569414 Free PMC article. Review.
-
Disclosing the crosstalk among DNA methylation, transcription factors, and histone marks in human pluripotent cells through discovery of DNA methylation motifs.Genome Res. 2013 Dec;23(12):2013-29. doi: 10.1101/gr.155960.113. Epub 2013 Oct 22. Genome Res. 2013. PMID: 24149073 Free PMC article.
-
Promoter Demethylation Upregulates STEAP1 Gene Expression in Human Prostate Cancer: In Vitro and In Silico Analysis.Life (Basel). 2021 Nov 17;11(11):1251. doi: 10.3390/life11111251. Life (Basel). 2021. PMID: 34833128 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases